Capricor Therapeutics, Inc. Banner Image

Capricor Therapeutics, Inc. has reached its limit for free report views

Work for Capricor Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Upgrade Profile

Capricor Therapeutics, Inc.

Ticker CAPR

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Los Angeles, California

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor’s lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and…More

Visit website

REPORT RATINGS

4.8 / 5.0 (240)

Capricor Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 240 reviews.

Capricor Therapeutics, Inc.